title: New insights in celiac disease.
abstract: Celiac disease (CD) is an autoimmune disorder occurring in genetically susceptible subjects. The incidence of CD is around 1%, and it is much more common in first-degree relatives of CD patients, 10%-18%. However, the pattern of the genetic inheritance is still obscure. Environmental factors are undoubtedly affecting the disease's clinical presentation, time at presentation, and may have an effect on the characteristics of the disease. The clinical presentation of CD has shifted during the previous decades from the classical presentation in which the toddler suffers from diarrhea, constipation, vomiting, failure to thrive, abdominal distension, etc., to the child with a monosymptomatic presentation, such as anemia, as well as an enlarged list of extra-intestinal disorders. The diagnosis of CD is being established by symptoms consistent with CD and positive serology. The ultimate diagnosis should be made upon histological evaluation of the small bowel mucosa. The treatment of CD is a lifelong, strict gluten-free diet (GFD). Compliance with a GFD is quite difficult. Therefore, new strategies for prevention and treatment modalities other than GFD are greatly needed. Recently several promising therapeutic modalities have been developed; these include resuming traditional baking techniques. Another methodology is using probiotic-driven prolylendopeptidase. Another pathway to tackle the therapeutic option in CD is by down-regulation of the activity of zonulin-the active pump enabling gluten to enter the enterocytes. We are facing an era where other modalities beyond a GFD might allow CD patients to be able to tolerate occasionally a small amount of gluten in their diet.
authors.affiliation: Hadassah University Hospital, The Hebrew University Hadassah Medical School, Jerusalem, Israel; Editor-in-Chief, Journal of Pediatric Gastroenterology and Nutrition, Europe.
authors.forename: David
authors.initials: D
authors.lastname: Branski
keywords: Celiac disease; gluten; probiotics; zonulin
references.citation: J Pediatr. 1998 Aug;133(2):181-7
references.pmid: 9709703
references.citation: Am J Clin Nutr. 2008 Feb;87(2):415-23
references.pmid: 18258633
references.citation: Am J Gastroenterol. 2004 May;99(5):894-904
references.pmid: 15128357
references.citation: Clin Gastroenterol Hepatol. 2011 Jan;9(1):24-9
references.pmid: 20951830
references.citation: Aliment Pharmacol Ther. 2007 Sep 1;26(5):757-66
references.pmid: 17697209
references.citation: Gastroenterology. 2009 Dec;137(6):1912-33
references.pmid: 19766641
references.citation: J Pediatr Gastroenterol Nutr. 1984 Nov;3(5):672-5
references.pmid: 6594493
references.citation: J Exp Med. 1984 Nov 1;160(5):1544-57
references.pmid: 6491604
references.citation: Lancet. 2003 Jun 21;361(9375):2152-4
references.pmid: 12826451
references.citation: J Pediatr Gastroenterol Nutr. 1998 Oct;27(4):393-6
references.pmid: 9779965
references.citation: Am J Gastroenterol. 2006 Oct;101(10):2333-40
references.pmid: 17032199
references.citation: Arch Dis Child. 2006 Jan;91(1):39-43
references.pmid: 16287899
references.citation: J Pediatr. 2006 Sep;149(3):295-300
references.pmid: 16939736
references.citation: JAMA. 2005 May 18;293(19):2343-51
references.pmid: 15900004